Aisling Capital Management LP - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 45 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Aisling Capital Management LP ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$761,864
+55.3%
1,691,1510.0%0.37%
+58.1%
Q1 2023$490,434
-35.6%
1,691,1510.0%0.24%
-53.0%
Q4 2022$761,018
-14.5%
1,691,1510.0%0.50%
-15.1%
Q3 2022$890,000
+4.2%
1,691,1510.0%0.59%
-3.0%
Q2 2022$854,000
-78.0%
1,691,1510.0%0.61%
-71.0%
Q1 2022$3,890,000
-51.6%
1,691,1510.0%2.10%
-25.9%
Q4 2021$8,033,000
-40.3%
1,691,1510.0%2.83%
+5.7%
Q3 2021$13,445,000
+14.2%
1,691,1510.0%2.68%
+42.3%
Q2 2021$11,770,000
-12.1%
1,691,1510.0%1.88%
-21.9%
Q1 2021$13,394,000
+0.6%
1,691,1510.0%2.41%
+5.5%
Q4 2020$13,309,000
+11.0%
1,691,1510.0%2.29%
-40.3%
Q3 2020$11,990,000
-23.4%
1,691,1510.0%3.83%
-35.8%
Q2 2020$15,643,000
+160.0%
1,691,151
+31.0%
5.97%
+127.8%
Q1 2020$6,017,000
-39.0%
1,291,1510.0%2.62%
-30.6%
Q4 2019$9,864,000
-0.7%
1,291,1510.0%3.78%
-27.0%
Q3 2019$9,929,000
+12.3%
1,291,1510.0%5.18%
+37.0%
Q2 2019$8,844,000
-10.0%
1,291,151
+5.8%
3.78%
-49.6%
Q1 2019$9,828,000
+51.1%
1,220,911
+40.6%
7.49%
+9.2%
Q4 2018$6,506,000868,6216.86%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 524,929$2,588,0006.20%
DAFNA Capital Management LLC 349,592$1,723,0001.07%
Nantahala Capital Management 1,602,903$7,902,0000.39%
Sio Capital Management, LLC 129,583$639,0000.33%
Rock Springs Capital Management LP 524,089$2,584,0000.12%
Orbimed Advisors 1,469,524$7,244,0000.07%
Baker Brothers Advisors 1,137,872$5,609,0000.04%
Lee Financial Co 22,408$110,0000.04%
Spark Investment Management LLC 42,002$207,0000.01%
JENNISON ASSOCIATES LLC 1,385,067$6,565,0000.01%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders